NCT03632616

Quality of Life Assessment of Chronic Pancreatitis Endoscopic Interventions

UNKNOWN
Not specifiedAges 18+Observational
University of Colorado, Denver
~500 participants
Updated 2024-05-22 on ClinicalTrials.gov
What's tested:PANQOLI (quality of life instrument)

At a glance

Recruiting sites
0 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Quality of Life using the PANQOLI (PANcreatitis Quality of Life Instrument)
Measured over The outcome will be measured at 1, 3, and 6 months post-intervention.
Chronic Pancreatitis
2 sites across 2 states
Colorado1
Maryland1
  • Raj J Shah, MD · PRINCIPAL_INVESTIGATOR · Professor of Medicine; Director, Pancreas and Biliary Endoscopy

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with painful chronic pancreatitis, defined as either 1) the presence of pancreatic calcifications on cross-sectional imaging, 2) morphologic changes consistent with the Rosemont criteria on endoscopic ultrasound, or 3) endoscopic pancreatic function test results consistent with decreased pancreatic function.

Exclusion

Pregnant females
Prisoners
Patients under the age of 18
Patients lacking the capacity to consent
  • Change in Quality of Life using the PANQOLI (PANcreatitis Quality of Life Instrument)The outcome will be measured at 1, 3, and 6 months post-intervention.

    The primary outcome will be the change in quality of life using the PANQOLI (PANcreatitis Quality of Life Instrument) after endoscopic intervention.